STEM compared with GANX: revenue, margins and what each company keeps, and the suppliers and customers both name

STEMStem, Inc.

Mkt capRevenueRevenue

GANXGain Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

STEMStem, Inc.

GANXGain Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

rebased to 0%

STEM, solidGANX, dashed

Supply-chain overlap

Revenue flow

STEM: latest quarter is a loss; flow not drawable. GANX: latest quarter not drawable.Method ›

STEMStem, Inc.

2.19▼−8.37%· post 2.19

Mkt cap$21.4MRevenue$34MQ2 FY26Revenue$156MFY25

GANXGain Therapeutics, Inc.

1.14▼−4.30%· post 1.14

ClosedOct 30 '26

Mkt cap$49.3MRevenue—Revenue—

Compare

ClosedOct 30 '26

STEMStem, Inc.

GANXGain Therapeutics, Inc.

2.19▼−8.37%post 2.19

Price

1.14▼−4.30%post 1.14

$21.4M

Mkt cap

$49.3M

Q2 FY26$34M

Revenue

—

FY25$156M

Revenue

—

STEM2.19▼−8.37%vsGANX1.14▼−4.30%ClosedOct 30 '26

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only STEM 2

AMZNAmazon Web Servicessupplier

—Neovoltunlistedcustomer

Shared 0

No shared counterparties.

Only GANX 1

—Minoryx Therapeutics, S.Lunlistedsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR